Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Surgery Partners (SGRY) EPS (Basic): 2013-2024

Historic EPS (Basic) for Surgery Partners (SGRY) over the last 11 years, with FY2024 value amounting to -$1.33.

  • Surgery Partners' EPS (Basic) rose 2800.0% to -$0.18 in Q3 2025 from the same period last year, while for Sep 2025 it was -$0.18, marking a year-over-year increase of 2800.0%. This contributed to the annual value of -$1.33 for FY2024, which is 137777.78% down from last year.
  • According to the latest figures from FY2024, Surgery Partners' EPS (Basic) is -$1.33, which was down 137777.78% from -$0.09 recorded in FY2023.
  • Surgery Partners' 5-year EPS (Basic) high stood at -$0.09 for FY2023, and its period low was -$3.19 during FY2020.
  • For the 5-year period, Surgery Partners' EPS (Basic) averaged around -$1.26, with its median value being -$1.12 (2021).
  • As far as peak fluctuations go, Surgery Partners' EPS (Basic) surged by 8474.58% in 2023, and later tumbled by 137777.78% in 2024.
  • Surgery Partners' EPS (Basic) (Annual) stood at -$3.19 in 2020, then skyrocketed by 64.89% to -$1.12 in 2021, then soared by 47.32% to -$0.59 in 2022, then skyrocketed by 84.75% to -$0.09 in 2023, then plummeted by 1377.78% to -$1.33 in 2024.
  • Its EPS (Basic) stands at -$1.33 for FY2024, versus -$0.09 for FY2023 and -$0.59 for FY2022.